Article Text

Download PDFPDF
Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study

Footnotes

  • Competing interests: None declared.

  • Funding: The POEMAS study is supported by unrestricted educational grants from: Actelion Pharmaceutical Nederland, Calea Nederland, Encysive Pharmaceuticals Inc, GlaxoSmithKline Nederland, Pfizer Nederland, Tefa Portanje and the Dutch patients association for pulmonary hypertension PHA-NL.

  • Contributors: MCV and PLAvD had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

  • Ethics approval: Ethics approval was obtained.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared.

  • Funding: The POEMAS study is supported by unrestricted educational grants from: Actelion Pharmaceutical Nederland, Calea Nederland, Encysive Pharmaceuticals Inc, GlaxoSmithKline Nederland, Pfizer Nederland, Tefa Portanje and the Dutch patients association for pulmonary hypertension PHA-NL.

  • Contributors: MCV and PLAvD had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

  • Ethics approval: Ethics approval was obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.